Western blot analysis results exhibited that the expression of TET1 and p53 was upregulated in sh-EZH2-treated GIST-T1 cells, which was negated by sh-TET1 treatment (Fig. 4A). The gene discussed is TP53; the disease is gastrointestinal stromal tumor.